|
1
|
Wu R, Li F, Zhu J, Tang R, Qi Q, Zhou X,
Li R, Wang W, Hua D and Chen W: A functional variant at mir-132-3p,
mir-212-3p and mir-361-5p binding site in cd80 gene alters
susceptibility to gastric cancer in a Chinese Han population. Med
Oncol. 31:602014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu YJ and Fan Y: Mir-215/192 participates
in gastric cancer progression. Clin Transl Oncol. 17:34–40. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen ZY, Zhang ZZ, Liu H, Zhao EH and Cao
H: Mir-375 inhibits the proliferation of gastric cancer cells by
repressing ERBB2 expression. Exp Ther Med. 7:1757–1761.
2014.PubMed/NCBI
|
|
4
|
Li H, Xie S, Liu M, Chen Z, Liu X, Wang L,
Li D and Zhou Y: The clinical significance of downregulation of
mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric
cancer tumorigenesis. Int J Oncol. 45:197–208. 2014.PubMed/NCBI
|
|
5
|
Xia J, Guo X, Yan J and Deng K: The role
of mir-148a in gastric cancer. J Cancer Res Clin Oncol.
140:1451–1456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng Y, Li S, Ding Y, Wang Q, Luo H, Shi
Q, Hao Z, Xiao G and Tong S: The role of mir-18a in gastric cancer
angiogenesis. Hepatogastroenterology. 60:1809–1813. 2013.PubMed/NCBI
|
|
7
|
Duan Y, Hu L, Liu B, Yu B, Li J, Yan M, Yu
Y, Li C, Su L, Zhu Z, et al: Tumor suppressor miR-24 restrains
gastric cancer progression by downregulating regIV. Mol Cancer.
13:1272014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He XJ, Ma YY, Yu S, Jiang XT, Lu YD, Tao
L, Wang HP, Hu ZM and Tao HQ: Up-regulated miR-199a-5p in gastric
cancer functions as an oncogene and targets klotho. BMC Cancer.
14:2182014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hornstein E, Mansfield JH, Yekta S, Hu JK,
Harfe BD, McManus MT, Baskerville S, Bartel DP and Tabin CJ: The
microRNA-miR-196 acts upstream of hoxb8 and shh in limb
development. Nature. 438:671–674. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sehm T, Sachse C, Frenzel C and Echeverri
K: miR-196 is an essential early-stage regulator of tail
regeneration, upstream of key spinal cord patterning events. Dev
Biol. 334:468–480. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kawasaki H and Taira K: MicroRNA-196
inhibits HOXB8 expression in myeloid differentiation of HL60 cells.
Nucleic Acids Symp Ser (Oxf). 48:211–212. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brest P, Lapaquette P, Souidi M, Lebrigand
K, Cesaro A, Vouret-Craviari V, Mari B, Barbry P, Mosnier JF,
Hébuterne X, et al: A synonymous variant in IRGM alters a binding
site for miR-196 and causes deregulation of IRGM-dependent
xenophagy in crohn's disease. Nat Genet. 43:242–245. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hezova R, Kovarikova A, Bienertova-Vasku
J, Sachlova M, Redova M, Vasku A, Svoboda M, Radova L, Kiss I,
Vyzula R and Slaby O: Evaluation of SNPs in miR-196-a2, miR-27a and
miR-146a as risk factors of colorectal cancer. World J
Gastroenterol. 18:2827–2831. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hou W, Tian Q, Zheng J and Bonkovsky HL:
MicroRNA-196 represses Bach1 protein and hepatitis C virus gene
expression in human hepatoma cells expressing hepatitis C viral
proteins. Hepatology. 51:1494–1504. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen C, Zhang Y, Zhang L, Weakley SM and
Yao Q: MicroRNA-196: Critical roles and clinical applications in
development and cancer. J Cell Mol Med. 15:14–23. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Popovic R, Riesbeck LE, Velu CS, Chaubey
A, Zhang J, Achille NJ, Erfurth FE, Eaton K, Lu J, Grimes HL, et
al: Regulation of mir-196b by MLL and its overexpression by MLL
fusions contributes to immortalization. Blood. 113:3314–3322. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schotte D, Lange-Turenhout EA, Stumpel DJ,
Stam RW, Buijs-Gladdines JG, Meijerink JP, Pieters R and Den Boer
ML: Expression of miR-196b is not exclusively MLL-driven but is
especially linked to activation of HOXA genes in pediatric acute
lymphoblastic leukemia. Haematologica. 95:1675–1682. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Z, Huang H, Chen P, He M, Li Y,
Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, et al: miR-196b
directly targets both HOXA9/MEIS1 oncogenes and FAS tumour
suppressor in MLL-rearranged leukaemia. Nat Commun. 3:6882012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abbud-Antaki RA, Marhefka JN, DeLuca AL
and Zuromskis MP: The cancer biochip system: a functional genomic
assay for anchorage-independent three-dimensional breast cancer
cell growth. Horm Cancer. 3:261–270. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guadamillas MC, Cerezo A and Del Pozo MA:
Overcoming anoikis-pathways to anchorage-independent growth in
cancer. J Cell Sci. 124:3189–3197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Okabe H, Ishimoto T, Mima K, Nakagawa S,
Hayashi H, Kuroki H, Imai K, Nitta H, Saito S, Hashimoto D, et al:
CD44s signals the acquisition of the mesenchymal phenotype required
for anchorage-independent cell survival in hepatocellular
carcinoma. Br J Cancer. 110:958–966. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marshall J: Transwell(®) invasion assays.
Methods Mol Biol. 769:97–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tapia O, Riquelme I, Leal P, Sandoval A,
Aedo S, Weber H, Letelier P, Bellolio E, Villaseca M, Garcia P and
Roa JC: The Pi3K/AKT/mTOR pathway is activated in gastric cancer
with potential prognostic and predictive significance. Virchows
Arch. 465:25–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sukawa Y, Yamamoto H, Nosho K, Ito M,
Igarashi H, Naito T, Mitsuhashi K, Matsunaga Y, Takahashi T, Mikami
M, et al: HER2 expression and Pi3K-Akt pathway alterations in
gastric cancer. Digestion. 89:12–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xie X, Tang B, Zhou J, Gao Q and Zhang P:
Inhibition of the Pi3K/Akt pathway increases the chemosensitivity
of gastric cancer to vincristine. Oncol Rep. 30:773–782.
2013.PubMed/NCBI
|
|
26
|
Ye B, Jiang LL, Xu HT, Zhou DW and Li ZS:
Expression of Pi3K/AKT pathway in gastric cancer and its blockade
suppresses tumor growth and metastasis. Int J Immunopathol
Pharmacol. 25:627–636. 2012.PubMed/NCBI
|
